{
    "title": "Drugmaker Novo Nordisk seeks obesity, diabetes 'bolt-on' deals",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12733951/Novo-Nordisk-prefers-bolt-acquisitions-not-large-deals-CEO-says.html",
    "date": "2023-11-10",
    "keywords": [
        "company",
        "disease",
        "year",
        "drug",
        "demand",
        "bolton",
        "mampa",
        "strategy",
        "novo",
        "maggie",
        "fick",
        "jacob",
        "gronholtpedersen",
        "development",
        "companys",
        "wegovy",
        "obesity",
        "space",
        "interview",
        "production",
        "market",
        "co",
        "dealsceo",
        "context",
        "paragraphs",
        "londoncopenhagen",
        "friday",
        "weightloss",
        "medicine",
        "jorgensen",
        "blood",
        "stronghold",
        "stage",
        "phase",
        "number",
        "understanding",
        "set",
        "engineering",
        "research",
        "rampd",
        "engine",
        "month",
        "hypertension",
        "biotech",
        "firm",
        "series",
        "century",
        "share",
        "price",
        "week",
        "growth",
        "ingredient",
        "semaglutide",
        "selfinjection",
        "healthcare",
        "banker",
        "condition",
        "anonymity",
        "earlystage",
        "nordisk",
        "reporting",
        "copenhagen",
        "editing",
        "terje",
        "solsvik",
        "sitholematarise",
        "barbara",
        "lewis"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}